Month: May 2024

Contacts Investor Contact: Michael Steele, CFA, IRC Zebra Technologies +1-847-518-6432 investorrelations@zebra.com Media Contact: Therese Van Ryne Zebra Technologies +1-847-370-2317 Therese.vanryne@zebra.com...

Inventory and new listings are rising nationwide, while price cuts hit a seasonal high point SEATTLE, May 15, 2024 /PRNewswire/...

The healthcare company expands access by launching its brand of naloxone, a life-saving medication used to reverse the effects of...

Contacts Investor Relations: Betsy Brod Affinity Growth Advisors Betsy.brod@affinitygrowth.com (917) 923-8541 Media: Robert Cavosi RooneyPartners rcavosi@rooneypartners.com (646) 638-9891 Virpax® Pharmaceuticals,...

CHATHAM, N.J., May 15, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated...

Reported revenues of $6.5 million in 1Q24, up 116% compared to 1Q23 Reported gross margin of 85% in 1Q24 Secured...

U.S. FDA clears Investigational New Drug application for THB335 Phase 1 SAD/MAD clinical trial initiated and subject screening underway, with results...

Reported Gross Profit of Approximately $0.22 Million for Third Quarter Fiscal 2024, up 47% Year-Over-YearSecured a USD$2 million marketing contract...

CULVER CITY, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or “the Company”), a leading,...

REDWOOD CITY, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Nasdaq: SLNO), (“Soleno” or the “Company”), a clinical-stage...

— Received Rare Pediatric Disease and Orphan Drug Designation for Duchenne musculardystrophy (Duchenne) gene therapy candidate SGT-003 with patient dosing...

AUBURN HILLS, Mich., May 15, 2024 (GLOBE NEWSWIRE) -- SPAR Group, Inc. (NASDAQ: SGRP) (“SPAR,” “SPAR Group” or the “Company”),...

Denifanstat Phase 2b FASCINATE-2 clinical data to be presented as an oral presentation at the EASL International Liver Congress 2024...

NEW YORK, May 15, 2024 /PRNewswire/ -- SunCar Technology Group Inc. (NASDAQ: SDA), an innovative leader in cloud-based B2B auto services...

Real estate investors bought 19% of U.S. homes that sold in the first quarter—the highest share in almost two years...

HERZLIYA, Israel, May 15, 2024 (GLOBE NEWSWIRE) -- Playtika Holding Corp. (NASDAQ: PLTK) today announced that Craig Abrahams, Playtika’s President...

Provided Positive, Updated Data from Phase 2 VERSATILE-002 Clinical Trial with Versamune® HPV in Combination with KEYTRUDA® in Recurrent or...

Contacts Media: James Robinson 530-913-0844 jrobinson@marqeta.com Marqeta (NASDAQ: MQ), the global modern card issuing platform that enables embedded finance solutions...

MARIETTA, Ga., May 15, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that...

INDIO, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ: LGIH) today announced the opening of a new...

SHELTON, Conn., May 15, 2024 /PRNewswire/ -- Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused...

SAN JOSE, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- Infinera (Nasdaq: INFN) announced today that Indonesian network operator Super Sistem...

NASHUA, N.H., May 15, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create...

NORCROSS, Ga., May 15, 2024 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target...

FORT PIERCE, FL / ACCESSWIRE / May 15, 2024 / Forza X1, Inc. (Nasdaq:FRZA) ("Forza," the "Company"), a developer of...

FREMONT, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the...

Contacts Media Contacts: Susan Baldwin Digimarc Corporation 509-939-1137 PR@digimarc.com Anneka Kumli Grove Partners 720-422-5258 anneka@thegrovepartners.com Digimarc Corporation (NASDAQ: DMRC), the...

- CervoMed on track to complete enrollment in 2Q 2024 in its RewinD-LB Phase 2b clinical trial evaluating neflamapimod in...

Contacts Angie Wirick AtriCure, Inc. Chief Financial Officer (513) 755-5334 awirick@atricure.com Marissa Bych Gilmartin Group Investor Relations marissa@gilmartinir.com AtriCure, Inc....

Growth Continues; Revenue Up 10%; Backlog Over $110 Million Contacts Richard L. Davis Chief Financial Officer (502) 329-2000 Sypris Solutions,...

Ondas Networks entered into $2.8 million agreement with industry partner to provide on-locomotive radio upgrade in the 220 MHz frequency...

PALO ALTO, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage...

Q1 2024 OvaSuiteSM revenue of $2.2 million and volume of 5,829 unitsQ1 2024 cash utilization of $4.4 million, a decrease...

SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- AppTech Payments Corp. (NASDAQ: APCX), a pioneering Fintech company powering frictionless commerce,...